Photobiomodulation shows promise as safe and tolerable adjunct therapy for Parkinson’s Disease, recent trial suggests Post author: Post published: December 5, 2023 Post category:uncategorized A safe and feasible treatment option for reducing the motor signs of Parkinson’s disease. You Might Also Like Depression may increase dementia risk in both midlife and late life May 29, 2025 Real-world study finds lower weight loss with GLP-1 drugs due to early discontinuation June 10, 2025 APOBEC proteins linked to DNA repeat expansion in Huntington’s disease January 22, 2025